Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
PATIENT REVENUES, NET	$ 475,718	$ 475,020
OTHER OPERATING INCOME	23,802	0
EXPENSES:
Operating	389,248	380,870
Lease and rent expense	54,001	52,990
Professional liability	8,310	6,996
Government settlement expense	0	3,100
General and administrative	27,691	28,009
Depreciation and amortization	9,069	9,122
Total expenses	488,319	481,087
OPERATING INCOME (LOSS)	11,201	(6,067)
OTHER INCOME (EXPENSE):
Other income	53	281
Interest expense, net	(5,008)	(5,994)
Debt retirement costs	(247)	0
Total other income (expense)	(5,202)	(5,713)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	5,999	(11,780)
(PROVISION) BENEFIT FOR INCOME TAXES	531	(15,694)
INCOME (LOSS) FROM CONTINUING OPERATIONS	6,530	(27,474)
INCOME (LOSS) FROM DISCONTINUED OPERATIONS:
Operating loss, net of income tax (provision) benefit of $365 and ($517), respectively	(1,371)	(9,322)
Gain on lease modification, net of tax	0	733
INCOME (LOSS) FROM DISCONTINUED OPERATIONS	(1,371)	(8,589)
NET INCOME (LOSS)	$ 5,159	$ (36,063)
Per common share – basic
Continuing operations (in dollars per share)	$ 0.99	$ (4.25)
Discontinued operations (in dollars per share)	(0.21)	(1.33)
Net income (loss) (in dollars per share)	0.78	(5.58)
Per common share – diluted
Continuing operations (in dollars per share)	0.97	(4.25)
Discontinued operations (in dollars per share)	(0.20)	(1.33)
Diluted net income (loss) per common share (in dollars per share)	0.77	(5.58)
DIVIDENDS DECLARED PER SHARE OF COMMON STOCK (in dollars per share)	$ 0	$ 0
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	6,615	6,459
Diluted (in shares)	6,705	6,459